Blueprint Medicines Corporation (BPMC)
USD 78.44
(-3.97%)
USD 78.44
(-3.97%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -506.98 Million USD | 9.06% |
| 2022 | -557.51 Million USD | 13.44% |
| 2021 | -644.08 Million USD | -305.2% |
| 2020 | 313.88 Million USD | 195.49% |
| 2019 | -328.7 Million USD | -38.9% |
| 2018 | -236.64 Million USD | -59.76% |
| 2017 | -148.11 Million USD | -104.32% |
| 2016 | -72.49 Million USD | -37.38% |
| 2015 | -52.76 Million USD | -30.99% |
| 2014 | -40.28 Million USD | -92.64% |
| 2013 | -20.91 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -56.27 Million USD | -12.57% |
| 2024 Q2 | -49.99 Million USD | -156.09% |
| 2024 Q1 | 89.13 Million USD | 180.36% |
| 2023 Q3 | -133.71 Million USD | -0.69% |
| 2023 Q4 | -110.91 Million USD | 17.05% |
| 2023 FY | -506.98 Million USD | 9.06% |
| 2023 Q1 | -129.56 Million USD | 18.33% |
| 2023 Q2 | -132.79 Million USD | -2.5% |
| 2022 Q2 | -159.7 Million USD | -50.67% |
| 2022 Q1 | -105.99 Million USD | 66.74% |
| 2022 FY | -557.51 Million USD | 13.44% |
| 2022 Q4 | -158.63 Million USD | -19.13% |
| 2022 Q3 | -133.16 Million USD | 16.62% |
| 2021 Q2 | -108.44 Million USD | -8.76% |
| 2021 Q4 | -318.68 Million USD | -171.82% |
| 2021 FY | -644.08 Million USD | -305.2% |
| 2021 Q1 | -99.71 Million USD | -16.39% |
| 2021 Q3 | -117.24 Million USD | -8.11% |
| 2020 Q4 | -85.66 Million USD | -113.51% |
| 2020 FY | 313.88 Million USD | 195.49% |
| 2020 Q1 | -110.95 Million USD | -67.27% |
| 2020 Q2 | -123.47 Million USD | -11.28% |
| 2020 Q3 | 633.97 Million USD | 613.45% |
| 2019 FY | -328.7 Million USD | -38.9% |
| 2019 Q1 | -87.4 Million USD | -8.82% |
| 2019 Q2 | -99.68 Million USD | -14.04% |
| 2019 Q3 | -94.27 Million USD | 5.42% |
| 2019 Q4 | -66.33 Million USD | 29.64% |
| 2018 Q2 | -27.04 Million USD | 52.17% |
| 2018 FY | -236.64 Million USD | -59.76% |
| 2018 Q4 | -80.32 Million USD | -10.45% |
| 2018 Q3 | -72.72 Million USD | -168.87% |
| 2018 Q1 | -56.54 Million USD | -15.34% |
| 2017 Q1 | -27.97 Million USD | -31.58% |
| 2017 FY | -148.11 Million USD | -104.32% |
| 2017 Q4 | -49.02 Million USD | -30.03% |
| 2017 Q3 | -37.7 Million USD | -12.84% |
| 2017 Q2 | -33.41 Million USD | -19.43% |
| 2016 Q1 | -15.5 Million USD | 0.46% |
| 2016 Q4 | -21.26 Million USD | -26.31% |
| 2016 Q3 | -16.83 Million USD | 10.9% |
| 2016 Q2 | -18.89 Million USD | -21.87% |
| 2016 FY | -72.49 Million USD | -37.38% |
| 2015 Q4 | -15.57 Million USD | -23.2% |
| 2015 FY | -52.76 Million USD | -30.99% |
| 2015 Q3 | -12.64 Million USD | 2.6% |
| 2015 Q2 | -12.98 Million USD | -12.17% |
| 2015 Q1 | -11.57 Million USD | 20.02% |
| 2014 Q1 | -7.02 Million USD | 0.0% |
| 2014 Q2 | -8.28 Million USD | -17.93% |
| 2014 Q3 | -10.5 Million USD | -26.74% |
| 2014 Q4 | -14.46 Million USD | -37.75% |
| 2014 FY | -40.28 Million USD | -92.64% |
| 2013 FY | -20.91 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -246.305% |
| Alkermes plc | 355.75 Million USD | 242.509% |
| Agenus Inc. | -245.76 Million USD | -106.291% |
| Aptorum Group Limited | -2.82 Million USD | -17848.579% |
| Ardelyx, Inc. | -66.06 Million USD | -667.379% |
| Dyadic International, Inc. | -6.79 Million USD | -7360.627% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -54064.957% |
| Lantern Pharma Inc. | -15.96 Million USD | -3076.286% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -2564.287% |
| Novavax, Inc. | -545.06 Million USD | 6.986% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -769.717% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -587.063% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -2633.643% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -4976.948% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -759.547% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -35.691% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1982.986% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1257.75% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -208.058% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -591.213% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -2398.566% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -714.367% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1460.671% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -282.65% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -15.16% |
| AlloVir, Inc. | -190.41 Million USD | -166.248% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -146.978% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1681.892% |
| Bicycle Therapeutics plc | -180.66 Million USD | -180.623% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -183.147% |
| ChromaDex Corporation | -4.93 Million USD | -10166.991% |
| Chimerix, Inc. | -82.09 Million USD | -517.558% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -1036.651% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -396.702% |
| CRISPR Therapeutics AG | -153.61 Million USD | -230.046% |
| Precision BioSciences, Inc. | -61.31 Million USD | -726.798% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -215.038% |
| Fortress Biotech, Inc. | -60.63 Million USD | -736.097% |
| Fortress Biotech, Inc. | -60.63 Million USD | -736.097% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -521.456% |
| ImmuCell Corporation | -5.77 Million USD | -8679.555% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -348.813% |
| Immix Biopharma, Inc. | -15.42 Million USD | -3186.545% |
| Incyte Corporation | 597.59 Million USD | 184.837% |
| Innoviva, Inc. | 179.72 Million USD | 382.093% |
| IO Biotech, Inc. | -86.08 Million USD | -488.948% |
| Jaguar Health, Inc. | -41.3 Million USD | -1127.564% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -231.379% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1072.09% |
| ContextLogic Inc. | -317 Million USD | -59.932% |
| MiMedx Group, Inc. | 67.43 Million USD | 851.767% |
| MEI Pharma, Inc. | 17.77 Million USD | 2951.749% |
| NextCure, Inc. | -62.72 Million USD | -708.29% |
| Onconetix, Inc. | -37.4 Million USD | -1255.221% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1184.187% |
| Opthea Limited | -220.24 Million USD | -130.194% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -890.996% |
| Vaxcyte, Inc. | -402.26 Million USD | -26.032% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1080.62% |
| Precigen, Inc. | -95.9 Million USD | -428.637% |
| Pharming Group N.V. | -10.54 Million USD | -4706.447% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -151.49% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -1965.697% |
| PureTech Health plc | -65.69 Million USD | -671.7% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -1920.581% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -138.895% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1982.986% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -96.634% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -1761.311% |
| Acelyrin, Inc. | -381.64 Million USD | -32.843% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -4041967.531% |
| Summit Therapeutics Inc. | -614.92 Million USD | 17.554% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1386.713% |
| Senti Biosciences, Inc. | -92.91 Million USD | -445.619% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -384.23% |
| Elevation Oncology, Inc. | -45.7 Million USD | -1009.277% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1342.755% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -3778.437% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -7483.904% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1626.667% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -5863.816% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -781.512% |
| Seer, Inc. | -86.27 Million USD | -487.624% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -656.749% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -670.902% |
| ESSA Pharma Inc. | -26.58 Million USD | -1807.221% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1273.962% |
| GT Biopharma, Inc. | -7.59 Million USD | -6573.476% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -110.052% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -876.377% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 809.962% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -831.579% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -932.134% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -4996.471% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 11.497% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -14029.989% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -892.957% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -106.431% |
| Aptose Biosciences Inc. | -51.2 Million USD | -890.068% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -415.763% |
| Soligenix, Inc. | -6.14 Million USD | -8156.087% |
| Century Therapeutics, Inc. | -136.67 Million USD | -270.947% |
| Kura Oncology, Inc. | -152.63 Million USD | -232.163% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -468.253% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -4711.008% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 89757.099% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -89000.879% |
| Autolus Therapeutics plc | -208.38 Million USD | -143.294% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -605.143% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -616.13% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -2239.782% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -125.076% |
| GRI Bio, Inc. | -13.03 Million USD | -3788.809% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -12162.049% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -308.581% |
| IGM Biosciences, Inc. | -246.41 Million USD | -105.743% |
| INmune Bio, Inc. | -30 Million USD | -1589.496% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -358.564% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1101.561% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3076.262% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -3109.779% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -749.433% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -401.136% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -83.606% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -113.115% |
| Verastem, Inc. | -87.36 Million USD | -480.292% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -835.602% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -214.241% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -334.59% |
| Histogen Inc. | -10.62 Million USD | -4673.411% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -3448.629% |
| Surrozen, Inc. | -43.04 Million USD | -1077.882% |
| Organovo Holdings, Inc. | -14.67 Million USD | -3355.688% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -9866.21% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -868.655% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -1906.824% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -1782.04% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -5966.516% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -235.562% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -936.225% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1605.581% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -4766.562% |
| Apollomics, Inc. | -172.6 Million USD | -193.732% |
| Amarin Corporation plc | -59.11 Million USD | -757.667% |
| Mesoblast Limited | -87.95 Million USD | -476.406% |
| Turnstone Biologics Corp. | -55.2 Million USD | -818.449% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -244.976% |
| Synaptogenix, Inc. | -6.03 Million USD | -8295.854% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -3027.986% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -549.813% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10480.979% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -5933.946% |
| Exelixis, Inc. | 207.76 Million USD | 344.018% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1175.111% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -252.199% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 4.094% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4065.156% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -6404.223% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1548.782% |
| Gritstone bio, Inc. | -138.49 Million USD | -266.08% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -686.448% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -12574.758% |
| Avid Bioservices, Inc. | -140.75 Million USD | -260.194% |
| Insmed Incorporated | -749.56 Million USD | 32.363% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -3237.725% |
| MediWound Ltd. | -6.71 Million USD | -7448.898% |
| OmniAb, Inc. | -50.61 Million USD | -901.569% |
| Alector, Inc. | -130.39 Million USD | -288.818% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -345.802% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -877.846% |
| Zai Lab Limited | -334.62 Million USD | -51.51% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -56.483% |
| Aura Biosciences, Inc. | -76.4 Million USD | -563.522% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -116.076% |
| Immunic, Inc. | -93.61 Million USD | -441.58% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -273.076% |
| Veracyte, Inc. | -74.4 Million USD | -581.393% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -6505.181% |
| FibroGen, Inc. | -284.23 Million USD | -78.37% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1832.693% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -7140.674% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -2592.042% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 222.214% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -2147.768% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1128.97% |
| TG Therapeutics, Inc. | 12.67 Million USD | 4100.821% |
| Galecto, Inc. | -38.34 Million USD | -1222.027% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -2587.289% |
| Fortrea Holdings Inc. | -3.4 Million USD | -14811.294% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -300.322% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -2811.86% |
| XBiotech Inc. | -24.55 Million USD | -1964.519% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -686.448% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -708.845% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -415.092% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -2266.099% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -818.566% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 16.427% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -642.779% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -890376.692% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -123.795% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -2176.787% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -130.751% |
| NexImmune, Inc. | -32.34 Million USD | -1467.456% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -9490.029% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -3509.482% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 112.823% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -1993.159% |
| Scopus BioPharma Inc. | -11.6 Million USD | -4266.852% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -334.069% |
| Ainos, Inc. | -13.77 Million USD | -3581.654% |
| Pluri Inc. | -20.88 Million USD | -2327.154% |
| Prothena Corporation plc | -147.02 Million USD | -244.821% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -345.227% |
| Celularity Inc. | -196.29 Million USD | -158.277% |
| Rallybio Corporation | -74.56 Million USD | -579.931% |
| Cue Biopharma, Inc. | -50.73 Million USD | -899.318% |
| MeiraGTx Holdings plc | -84.02 Million USD | -503.358% |
| Omeros Corporation | -117.81 Million USD | -330.329% |
| Humacyte, Inc. | -110.77 Million USD | -357.666% |
| Immunocore Holdings plc | -55.28 Million USD | -817.004% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -2719.084% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -2110.911% |
| CalciMedica, Inc. | -34.35 Million USD | -1375.635% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -649.145% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -258.533% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -205.801% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -78.985% |
| Pulmatrix, Inc. | -14.12 Million USD | -3490.284% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1340.5% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -513.5% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -5.36% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -383.436% |
| Cytokinetics, Incorporated | -526.24 Million USD | 3.66% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1305.751% |
| Nutriband Inc. | -5.48 Million USD | -9142.57% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1154.29% |
| Vor Biopharma Inc. | -117.86 Million USD | -330.147% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 111.658% |
| Evogene Ltd. | -23.87 Million USD | -2023.137% |
| ProKidney Corp. | -35.46 Million USD | -1329.412% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -323.323% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -6362.19% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 21.178% |
| CorMedix Inc. | -46.33 Million USD | -994.071% |
| BioLineRx Ltd. | -60.61 Million USD | -736.414% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -398.294% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1134.559% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1160.402% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -528.621% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -571.315% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -73.511% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1718.711% |
| MediciNova, Inc. | -8.57 Million USD | -5814.753% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -311.256% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -5952.215% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1852.434% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -111.916% |
| Biomea Fusion, Inc. | -117.25 Million USD | -332.377% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 19.09% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1620.573% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -231.012% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -142.159% |
| Absci Corporation | -110.56 Million USD | -358.535% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1581.539% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -402.776% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -114.881% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 3699.716% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -162.738% |
| Allakos Inc. | -185.7 Million USD | -173.011% |
| Imunon, Inc. | -19.51 Million USD | -2497.923% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -420.865% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 577.656% |
| BioAtla, Inc. | -123.46 Million USD | -310.64% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4065.156% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -3053.278% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -54.915% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1272.118% |
| XOMA Corporation | -40.83 Million USD | -1141.664% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -397.677% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -327.788% |
| aTyr Pharma, Inc. | -50.38 Million USD | -906.14% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -478.227% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -234.072% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -113.257% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1343.617% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -6165.296% |
| Akari Therapeutics, Plc | -10 Million USD | -4965.787% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -752939.733% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 280.041% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -7506.777% |
| UroGen Pharma Ltd. | -102.24 Million USD | -395.857% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -374.735% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -6418.863% |
| Orgenesis Inc. | -55.36 Million USD | -815.778% |
| Entera Bio Ltd. | -8.88 Million USD | -5603.499% |
| GH Research PLC | -35.58 Million USD | -1324.633% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2332.745% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -555.12% |
| Xencor, Inc. | -126.08 Million USD | -302.091% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -13363.2% |
| Replimune Group, Inc. | -215.79 Million USD | -134.939% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -2283.952% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 20306.616% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -7506.777% |
| Portage Biotech Inc. | -75.33 Million USD | -572.937% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -5952.215% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -424.53% |
| OncoCyte Corporation | -27.78 Million USD | -1724.931% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -3678.609% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -4458.586% |
| Purple Biotech Ltd. | -19.88 Million USD | -2450.221% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -7123.023% |
| scPharmaceuticals Inc. | -54.81 Million USD | -824.984% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -2796.035% |
| HilleVax, Inc. | -123.56 Million USD | -310.294% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -4916.167% |
| Tharimmune, Inc. | -9.31 Million USD | -5340.271% |
| Genprex, Inc. | -30.86 Million USD | -1542.827% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -114.892% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1584.668% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -28350.281% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -9472.934% |
| OKYO Pharma Limited | -16.82 Thousand USD | -3013095.479% |
| Savara Inc. | -54.69 Million USD | -826.878% |
| Curis, Inc. | -47.41 Million USD | -969.293% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1580.904% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -3182.494% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -9003.681% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1600.433% |
| BeiGene, Ltd. | -881.7 Million USD | 42.5% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -2280.877% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -16.183% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -542.118% |
| Erasca, Inc. | -125.04 Million USD | -305.451% |
| bluebird bio, Inc. | -211.91 Million USD | -139.242% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -10038.672% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 402.415% |
| DBV Technologies S.A. | -72.72 Million USD | -597.115% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -10038.672% |
| Moderna, Inc. | -4.71 Billion USD | 89.245% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1162.505% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -8803.829% |
| Molecular Templates, Inc. | -8.12 Million USD | -6140.571% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -739.544% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -355.106% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -274.567% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -958.002% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -258.472% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -163.492% |
| MacroGenics, Inc. | -9.05 Million USD | -5497.085% |
| RenovoRx, Inc. | -10.23 Million USD | -4854.887% |
| Adicet Bio, Inc. | -142.65 Million USD | -255.384% |
| Prime Medicine, Inc. | -198.13 Million USD | -155.881% |
| Aditxt, Inc. | -32.38 Million USD | -1465.691% |
| Adagene Inc. | -18.94 Million USD | -2575.89% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6833.851% |
| Quantum-Si incorporated | -95.96 Million USD | -428.328% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -325.933% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3377.789% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 483.121% |
| SciSparc Ltd. | -5.12 Million USD | -9798.165% |
| Vericel Corporation | -3.18 Million USD | -15832.872% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -421494.292% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1589.645% |
| Generation Bio Co. | -126.61 Million USD | -300.423% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -595.537% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -514.958% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -93.402% |
| Invivyd, Inc. | -198.64 Million USD | -155.224% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -48.253% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -5736.41% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2323.029% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -5034.535% |
| 2seventy bio, Inc. | -217.57 Million USD | -133.021% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1695.333% |
| Clene Inc. | -49.5 Million USD | -924.127% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -2174.742% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -925.578% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1852.434% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -54.537% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1457.894% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2331.444% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -413.185% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -578.203% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -215.279% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 17.572% |
| Evaxion Biotech A/S | -22.12 Million USD | -2191.453% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -527.953% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -153.406% |
| Trevena, Inc. | -40.28 Million USD | -1158.368% |
| Surrozen, Inc. | -43.04 Million USD | -1077.882% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -633.335% |
| Cingulate Inc. | -23.53 Million USD | -2054.175% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -7234.838% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1171.912% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -6475.094% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -462.004% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -727.243% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -752.031% |
| Clearmind Medicine Inc. | -11.95 Million USD | -4140.759% |
| Kronos Bio, Inc. | -112.67 Million USD | -349.961% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -632.668% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -19989569.707% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -490.237% |
| Statera Biopharma, Inc. | -174.4 Million USD | -190.688% |
| ImmunityBio, Inc. | -583.19 Million USD | 13.068% |
| Korro Bio, Inc. | -81.17 Million USD | -524.58% |
| Kineta, Inc. | -14.09 Million USD | -3495.886% |
| BioVie Inc. | -32.12 Million USD | -1478.38% |
| Codexis, Inc. | -76.24 Million USD | -564.984% |
| Celularity Inc. | -196.29 Million USD | -158.277% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -136.324% |
| Celcuity Inc. | -63.77 Million USD | -694.906% |
| Virax Biolabs Group Limited | -6.73 Million USD | -7429.238% |
| Cibus, Inc. | -267.62 Million USD | -89.437% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1157.214% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1315.721% |
| IN8bio, Inc. | -30 Million USD | -1589.552% |
| Kodiak Sciences Inc. | -260.49 Million USD | -94.626% |
| Annexon, Inc. | -134.23 Million USD | -277.678% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -332.709% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -728.026% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1507.228% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -38.412% |
| Eyenovia, Inc. | -27.26 Million USD | -1759.734% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 2448.127% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -94663.364% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -563.557% |
| Arcellx, Inc. | -70.69 Million USD | -617.193% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1123.387% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -278.867% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1587.865% |
| Moolec Science SA | -51.78 Million USD | -878.944% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -868.062% |
| Geron Corporation | -184.12 Million USD | -175.345% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1107.852% |
| Royalty Pharma plc | 1.13 Billion USD | 144.675% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -272.903% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -5601.701% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -2286.567% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -195.325% |
| Humacyte, Inc. | -110.77 Million USD | -357.666% |
| Structure Therapeutics Inc. | -89.62 Million USD | -465.704% |
| 89bio, Inc. | -142.18 Million USD | -256.556% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -635.186% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -4785.651% |
| Genelux Corporation | -28.29 Million USD | -1691.653% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1644.311% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -186.239% |
| Notable Labs, Ltd. | -11.26 Million USD | -4400.923% |
| Liquidia Corporation | -78.5 Million USD | -545.823% |
| Mustang Bio, Inc. | -51.6 Million USD | -882.489% |
| Immunovant, Inc. | -259.33 Million USD | -95.493% |
| Quantum-Si incorporated | -95.96 Million USD | -428.328% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -595.938% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -2515.882% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -428.163% |
| Acasti Pharma Inc. | -12.85 Million USD | -3844.48% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -2157.49% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3076.262% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -177.962% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -11686.168% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -3965.63% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1619.114% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1200.359% |
| PepGen Inc. | -78.62 Million USD | -544.805% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1603.06% |
| United Therapeutics Corporation | 984.8 Million USD | 151.481% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -2177.556% |
| Solid Biosciences Inc. | -96.01 Million USD | -428.026% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10480.979% |
| Immuneering Corporation | -53.47 Million USD | -848.137% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -9866.21% |
| Silo Pharma, Inc. | -3.7 Million USD | -13599.741% |
| Belite Bio, Inc | -31.63 Million USD | -1502.757% |
| XOMA Corporation | -40.83 Million USD | -1141.664% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -832.556% |
| Bionomics Limited | -15.49 Billion USD | 96.727% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -503.66% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1638.807% |
| uniQure N.V. | -308.47 Million USD | -64.35% |
| Cassava Sciences, Inc. | -97.21 Million USD | -421.497% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6833.851% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -310.746% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1510.7% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -6081.448% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1644.131% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -94663.364% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1832.693% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -2975.426% |
| Altimmune, Inc. | -88.44 Million USD | -473.207% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -234.457% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1638.807% |
| Compugen Ltd. | -18.75 Million USD | -2603.338% |
| Peak Bio, Inc. | -1259.26 USD | -40260370.435% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -1000.966% |
| Benitec Biopharma Inc. | -21.75 Million USD | -2230.854% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -49.646% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -511.163% |
| Zura Bio Limited | -60.36 Million USD | -739.934% |
| PolyPid Ltd. | -23.86 Million USD | -2024.383% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -3122.629% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -511.163% |
| Instil Bio, Inc. | -156.08 Million USD | -224.809% |
| argenx SE | -295.05 Million USD | -71.828% |
| Immunome, Inc. | -106.8 Million USD | -374.677% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1093.072% |
| Verona Pharma plc | -54.36 Million USD | -832.487% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -407.405% |
| Shattuck Labs, Inc. | -87.29 Million USD | -480.751% |
| CervoMed Inc. | -2.17 Million USD | -23243.17% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -306.723% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -3707.33% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1064.009% |
| Moolec Science SA | -51.78 Million USD | -878.944% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -2931844.924% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -275.218% |
| AnaptysBio, Inc. | -163.61 Million USD | -209.856% |
| Design Therapeutics, Inc. | -66.86 Million USD | -658.254% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -522.723% |
| NeurAxis, Inc. | -14.62 Million USD | -3366.158% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1238.324% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1389.64% |
| Achilles Therapeutics plc | -69.66 Million USD | -627.746% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -407.405% |
| 180 Life Sciences Corp. | -19.93 Million USD | -2443.171% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 16950.096% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -19989569.707% |
| Nutriband Inc. | -5.48 Million USD | -9142.57% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -403.475% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -943.027% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -557.644% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1392.446% |
| MoonLake Immunotherapeutics | -36 Million USD | -1308.005% |
| Palisade Bio, Inc. | -12.3 Million USD | -4021.821% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1103.551% |
| Beam Therapeutics Inc. | -132.52 Million USD | -282.551% |
| Neurogene Inc. | -36.31 Million USD | -1295.996% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -210.243% |
| AEON Biopharma, Inc. | -52.55 Million USD | -864.655% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -416.556% |
| Sesen Bio, Inc. | -19.88 Million USD | -2449.708% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -608.236% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -3951.368% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -14.176% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -354.425% |
| Athira Pharma, Inc. | -117.67 Million USD | -330.845% |
| Vaccinex, Inc. | -20.25 Million USD | -2403.501% |
| HCW Biologics Inc. | -24.99 Million USD | -1928.4% |
| XOMA Corporation | -40.83 Million USD | -1141.664% |
| Nektar Therapeutics | -276.05 Million USD | -83.653% |
| Arvinas, Inc. | -367.3 Million USD | -38.03% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -752939.733% |
| Merus N.V. | -154.93 Million USD | -227.215% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -420.368% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1515.37% |
| Rezolute, Inc. | -68.45 Million USD | -640.566% |
| Clene Inc. | -49.5 Million USD | -924.127% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3187.094% |
| BeyondSpring Inc. | -21.02 Million USD | -2311.224% |
| Synlogic, Inc. | -57.28 Million USD | -785.067% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -4160.012% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4583.022% |
| Peak Bio, Inc. | -1259.26 USD | -40260370.435% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1256.733% |
| Krystal Biotech, Inc. | 10.93 Million USD | 4737.614% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -254.289% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -55.945% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -10876.139% |
| MannKind Corporation | -11.93 Million USD | -4146.809% |
| Ikena Oncology, Inc. | -68.16 Million USD | -643.749% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -2312.486% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -445.537% |
| Gossamer Bio, Inc. | -179.81 Million USD | -181.944% |
| CohBar, Inc. | -11.96 Million USD | -4138.246% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1865.969% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1581.539% |
| Legend Biotech Corporation | -518.25 Million USD | 2.175% |
| Mural Oncology plc | -207.44 Million USD | -144.392% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -308.479% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -2671.961% |
| Disc Medicine, Inc. | -76.42 Million USD | -563.34% |
| Champions Oncology, Inc. | -7.27 Million USD | -6867.894% |
| REGENXBIO Inc. | -263.49 Million USD | -92.408% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -4676.976% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -967.222% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1234.748% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -406.159% |
| Vaxart, Inc. | -82.46 Million USD | -514.787% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 151999.402% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1250.426% |
| Cellectis S.A. | -101.05 Million USD | -401.671% |
| Longeveron Inc. | -21.41 Million USD | -2267.646% |
| Repare Therapeutics Inc. | -93.79 Million USD | -440.518% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 5.409% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -612.366% |
| Revolution Medicines, Inc. | -436.36 Million USD | -16.183% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -7615.477% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1544.77% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -631.23% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -683.205% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -5067.506% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 114.007% |
| Denali Therapeutics Inc. | -145.22 Million USD | -249.105% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -421494.292% |
| Veru Inc. | -93.15 Million USD | -444.251% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -1775.704% |
| Cingulate Inc. | -23.53 Million USD | -2054.175% |
| Passage Bio, Inc. | -102.06 Million USD | -396.741% |
| Context Therapeutics Inc. | -23.96 Million USD | -2015.588% |
| Exicure, Inc. | -16.91 Million USD | -2897.422% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -168.363% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1242.506% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -7690.975% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -174.523% |
| Nuvalent, Inc. | -126.21 Million USD | -301.67% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -4721.23% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -483.552% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1559.848% |
| OmniAb, Inc. | -50.61 Million USD | -901.569% |
| Anew Medical, Inc. | 1.34 Million USD | 37762.476% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -3059.763% |
| Lipocine Inc. | -16.35 Million USD | -3000.425% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -663.599% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -696.206% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1101.561% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -956.943% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -2456.523% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 6.372% |
| Ocugen, Inc. | -63.07 Million USD | -703.741% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -429.587% |
| Q32 Bio Inc. | -112.96 Million USD | -348.813% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -2848.953% |
| Alumis Inc. Common Stock | -154.99 Million USD | -227.101% |
| Equillium, Inc. | -13.33 Million USD | -3701.905% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -739.85% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -6246.951% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -2589.395% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -758.102% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -342.676% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -2658.653% |
| Dominari Holdings Inc. | -22.88 Million USD | -2115.645% |
| Edesa Biotech, Inc. | -8.37 Million USD | -5953.963% |
| vTv Therapeutics Inc. | -20.25 Million USD | -2403.625% |
| Bio-Techne Corporation | 168.1 Million USD | 401.588% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -43.994% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 493.459% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -316.134% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1236.314% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -350.084% |
| Nkarta, Inc. | -117.5 Million USD | -331.472% |
| BioCardia, Inc. | -11.57 Million USD | -4281.505% |
| Iterum Therapeutics plc | -38.37 Million USD | -1221.269% |